Raymond S.W. Yeung M.D., F.R.C.S (C), F.A.C.S.

 Raymond  S.W. Yeung M.D., F.R.C.S (C), F.A.C.S.

Bio

Dr. Raymond Yeung is a UW professor of surgery and an adjunct professor of pathology. Dr. Yeung established the Liver Tumor Clinic at UW Medical Center in…

Read Full Bio

Patient Care Philosophy

I believe in working with the patient in partnership to achieve the best outcome.

Personal Interests

Dr. Yeung is a concert-level pianist, enjoys playing and watching tennis, spending time with his family, and searching out the best food in every city.

Clinical Interests

Surgical treatment of liver and bile duct tumors; melanoma; minimally invasive image-guided therapy.

Research Interests

Pathogenesis of primary liver cancer; molecular carcinogenesis of fibrolamellar carcinoma (FLC); biomarkers in hepatocellular carcinoma (HCC); molecular pathogenesis of tuberous sclerosis complex (TSC); lymphangioleiomyomatosis (LAM).

Education

InstitutionCredentialYear
Univ. of TorontoMedical education1982
Fox Chase Cancer CenterFellowship
Fox Chase Cancer CenterFellowship
St. Michael's Hosp.(Toronto)Internship
Toronto General HospitalFellowship
University of TorontoResidency

DegreeDescriptionYear
MD1982

Board Certifications

CertificationSpecialtyYear
American Board of SurgerySurgery1988
Dr. Raymond Yeung is a UW professor of surgery and an adjunct professor of pathology. Dr. Yeung established the Liver Tumor Clinic at UW Medical Center in 1998, the first multi-disciplinary clinic of its kind in the Pacific Northwest. Dr. Yeung’s clinical focus is on the surgical treatment of hepatobiliary tumors (tumors of the liver and bile duct) and metastatic disease involving the liver. He specializes in robotic, laparoscopic and open liver resections, as well as various forms of minimally invasive radiofrequency ablation (RFA). Dr. Yeung also sees patients with melanoma requiring surgical excision, and is a renowned expert in diseases related to tuberous sclerosis and lymphangioleiomyomatosis (LAM).

Dr. Yeung has a robust academic research presence at the University of Washington. His labs are currently investigating the pathogenesis of primary liver cancer, molecular carcinogenesis of fibrolamellar carcinoma (FLC), biomarkers in hepatocellular carcinoma (HCC), and molecular pathogenesis of tuberous sclerosis complex (TSC). Dr. Yeung has received both local and national research funding to support his work.

Provider Locations